These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9202340)

  • 1. Polyglutamine domains are substrates of tissue transglutaminase: does transglutaminase play a role in expanded CAG/poly-Q neurodegenerative diseases?
    Cooper AJ; Sheu KF; Burke JR; Onodera O; Strittmatter WJ; Roses AD; Blass JP
    J Neurochem; 1997 Jul; 69(1):431-4. PubMed ID: 9202340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysine-rich histone (H1) is a lysyl substrate of tissue transglutaminase: possible involvement of transglutaminase in the formation of nuclear aggregates in (CAG)(n)/Q(n) expansion diseases.
    Cooper AJ; Wang J; Pasternack R; Fuchsbauer HL; Sheu RK; Blass JP
    Dev Neurosci; 2000; 22(5-6):404-17. PubMed ID: 11111157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transglutaminase-catalyzed inactivation of glyceraldehyde 3-phosphate dehydrogenase and alpha-ketoglutarate dehydrogenase complex by polyglutamine domains of pathological length.
    Cooper AJ; Sheu KR; Burke JR; Onodera O; Strittmatter WJ; Roses AD; Blass JP
    Proc Natl Acad Sci U S A; 1997 Nov; 94(23):12604-9. PubMed ID: 9356496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross linking of polyglutamine domains catalyzed by tissue transglutaminase is greatly favored with pathological-length repeats: does transglutaminase activity play a role in (CAG)(n)/Q(n)-expansion diseases?
    Cooper AJ; Jeitner TM; Gentile V; Blass JP
    Neurochem Int; 2002 Jan; 40(1):53-67. PubMed ID: 11738472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural characterization of transglutaminase-catalyzed cross-linking between glyceraldehyde 3-phosphate dehydrogenase and polyglutamine repeats.
    Ruoppolo M; Orrù S; Francese S; Caputo I; Esposito C
    Protein Sci; 2003 Jan; 12(1):170-9. PubMed ID: 12493840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis of inclusion bodies in (CAG)n/Qn-expansion diseases with special reference to the role of tissue transglutaminase and to selective vulnerability.
    Cooper AJ; Sheu KF; Burke JR; Strittmatter WJ; Gentile V; Peluso G; Blass JP
    J Neurochem; 1999 Mar; 72(3):889-99. PubMed ID: 10037459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue transglutaminase-catalyzed formation of high-molecular-weight aggregates in vitro is favored with long polyglutamine domains: a possible mechanism contributing to CAG-triplet diseases.
    Gentile V; Sepe C; Calvani M; Melone MA; Cotrufo R; Cooper AJ; Blass JP; Peluso G
    Arch Biochem Biophys; 1998 Apr; 352(2):314-21. PubMed ID: 9587422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of α-ketoglutarate-and pyruvate dehydrogenase complexes in E. coli by a glutathione S-transferase containing a pathological length poly-Q domain: A possible role of energy deficit in neurological diseases associated with poly-Q expansions?
    Cooper AJ; Sheu KF; Burke JR; Onodera O; Strittmatter WJ; Roses AD; Blass JP
    Age (Omaha); 1998 Jan; 21(1):25-30. PubMed ID: 23604331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptides containing glutamine repeats as substrates for transglutaminase-catalyzed cross-linking: relevance to diseases of the nervous system.
    Kahlem P; Terré C; Green H; Djian P
    Proc Natl Acad Sci U S A; 1996 Dec; 93(25):14580-5. PubMed ID: 8962095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transglutaminase potentiates ligand-dependent proteasome dysfunction induced by polyglutamine-expanded androgen receptor.
    Mandrusiak LM; Beitel LK; Wang X; Scanlon TC; Chevalier-Larsen E; Merry DE; Trifiro MA
    Hum Mol Genet; 2003 Jul; 12(13):1497-506. PubMed ID: 12812978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of amine acceptor protein substrates of transglutaminase in liver extracts: use of 5-(biotinamido) pentylamine as a probe.
    Ikura K; Kita K; Fujita I; Hashimoto H; Kawabata N
    Arch Biochem Biophys; 1998 Aug; 356(2):280-6. PubMed ID: 9705218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility to transglutaminase of gliadin peptides predicted by a mass spectrometry-based assay.
    Mamone G; Ferranti P; Melck D; Tafuro F; Longobardo L; Chianese L; Addeo F
    FEBS Lett; 2004 Mar; 562(1-3):177-82. PubMed ID: 15044021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysine residues of IGF-I are substrates for transglutaminases and modulate downstream IGF-I signalling.
    Sivaramakrishnan M; Croll TI; Gupta R; Stupar D; Van Lonkhuyzen DR; Upton Z; Shooter GK
    Biochim Biophys Acta; 2013 Dec; 1833(12):3176-3185. PubMed ID: 24036101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro modification of betaine-homocysteine S-methyltransferase by tissue-type transglutaminase.
    Ichikawa A; Ohashi Y; Terada S; Natsuka S; Ikura K
    Int J Biochem Cell Biol; 2004 Oct; 36(10):1981-92. PubMed ID: 15203112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cell adhesion molecule C-CAM is a substrate for tissue transglutaminase.
    Hunter I; Sigmundsson K; Beauchemin N; Obrink B
    FEBS Lett; 1998 Mar; 425(1):141-4. PubMed ID: 9541024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The carboxy-terminal lysine of alpha B-crystallin is an amine-donor substrate for tissue transglutaminase.
    Groenen PJ; Bloemendal H; de Jong WW
    Eur J Biochem; 1992 Apr; 205(2):671-4. PubMed ID: 1349282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of tissue transglutaminase on the solubility of proteins containing expanded polyglutamine repeats.
    Lai TS; Tucker T; Burke JR; Strittmatter WJ; Greenberg CS
    J Neurochem; 2004 Mar; 88(5):1253-60. PubMed ID: 15009681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Putative nucleotide binding sites of guinea pig liver transglutaminase.
    Takeuchi Y; Birckbichler PJ; Patterson MK; Lee KN
    FEBS Lett; 1992 Jul; 307(2):177-80. PubMed ID: 1353729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the transglutaminase enzymes in the nervous system and their possible involvement in neurodegenerative diseases.
    De Vivo G; Di Lorenzo R; Ricotta M; Gentile V
    Curr Med Chem; 2009; 16(36):4767-73. PubMed ID: 19929789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of substrate specificities of transglutaminases using synthetic peptides as acyl donors.
    Ohtsuka T; Ota M; Nio N; Motoki M
    Biosci Biotechnol Biochem; 2000 Dec; 64(12):2608-13. PubMed ID: 11210124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.